Publications

Peer-reviewed Articles:

  1. Fatourechi V , Morris JC 3rd, Sebo TJ. Coexistence of radioactive iodine-resistant benign struma ovarii with cervical primary papillary cancer of the thyroid: an unusual cause of thyroglobulin-positive radioactive iodine-negative whole-body scans. Thyroid. 2014 Sep; 24(9):1432-4. Epub 2014 Jul 14. PMID:24934079. DOI:10.1089/thy.2014.0010.
  2. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Karlin N, Sideras K, Morris JC 3rd, McIver B, Hay I, Fatourechi V , Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Cher Goh B, Isham CR, Harris P, Erlichman C, for the Endocrine Malignancies Disease Oriented Group Mayo Clinic Cancer Center and the Mayo Phase 2 Consortium. A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H. J Clin Endocrinol Metab. 2014 May; 99(5):1687-93. Epub 2014 Feb. PMID:24606083. PMCID:4010705. DOI:10.1210/jc.2013-3713.
  3. Fatourechi MM, Fatourechi V . An update on subclinical hypothyroidism and subclinical hyperthyroidism. Expert Rev. Endocrinol. Metab. 2014; 9(2):137-51.
  4. Fatourechi V . Thyroid and parathyroid office based ultrasonography - Review article. Iranian Journal of Public Health. 2014; 43(Suppl 1):11-8.
  5. Bartalena L, Fatourechi V . Extrathyroidal manifestations of Graves' disease: A 2014 update. J Endocrinol Invest. 2014; 37(8):691-700.
  6. Law JH, Dean DS, Scheithauer B, Earnest F 4th, Sebo TJ, Fatourechi V . Symptomatic amyloid goiters: report of five cases. Thyroid. 2013 Nov; 23(11):1490-5. Epub 2013 Sep 19. PMID:23544771. DOI:10.1089/thy.2012.0431.
  7. Fatourechi V . Thyroid dermopathy and acropachy. Best Pract Res Clin Endocrinol Metab. 2012 Aug; 26(4):553-65. Epub 2012 May 22. PMID:22863396. DOI:10.1016/j.beem.2011.10.001.
  8. Chindris AM, Diehl NN, Crook JE, Fatourechi V , Smallridge RC. Undetectable sensitive serum thyroglobulin ( PMID:22639286. DOI:10.1210/jc.2011-3017.
  9. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V , Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. Am J Manag Care. 2012 May; 18(5):e162-7. Epub 2012 May 01. PMID:22694109.
  10. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V , Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract. 2012 May; 8(3 Suppl):e1s-5s. PMID:22942830. PMCID:3348595. DOI:10.1200/JOP.2011.000496.
  11. Fatourechi MM, Hay ID, McIver B, Sebo TJ, Fatourechi V . Invasive fibrous thyroiditis (Riedel thyroiditis): the Mayo Clinic experience, 1976-2008. Thyroid. 2011 Jul; 21(7):765-72. Epub 2011 May 13. PMID:21568724. DOI:10.1089/thy.2010.0453.
  12. Fatourechi V . Thyroid dermopathy and acropachy. Expert Review of Dermatology. 2011; 6(1):75-90.
  13. McIver B, Fatourechi MM, Hay ID, Fatourechi V . Graves' disease after unilateral Riedel's thyroiditis. J Clin Endocrinol Metab. 2010 Jun; 95(6):2525-6. PMID:20525902. DOI:10.1210/jc.2009-2609.
  14. Fatourechi V . Subclinical hypothyroidism and subclinical hyperthyroidism. Expert Rev. Endocrinol. Metab. 2010; 5(3):359-73.
  15. Fatourechi V . Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009; 84(1):65-71. PMID:19121255. PMCID:2664572. DOI:10.1016/S0025-6196(11)60809-4.
  16. Stan M, Fatourechi V . Thyroid nodules and goiters: current standards of care. Consultant. 2007 Jan; 47(1):49-51, 54-6.
  17. Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S, Fatourechi V . Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab. 2007 Jan; 92(1):82-7. PMID:17077133.
  18. Fatourechi V . Grave's disease. BMJ Point of Care. 2007.
  19. Moayedoddin B, Booya F, Wermers RA, Lloyd RV, Rubin J, Thompson GB, Fatourechi V . Spectrum of malignant somatostatin-producing neuroendocrine tumors. Endocr Pract. 2006 Jul-Aug; 12(4):394-400. PMID:16901794.
  20. Castillo P, Woodruff B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Carter J, Sirven J, Hunder G, Fatourechi V , Mokri B, Drubach D, Pittock S, Lennon V, Boeve B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb; 63(2):197-202.
  21. Booya F, Sebo TJ, Kasperbauer JL, Fatourechi V . Primary squamous cell carcinoma of the thyroid: report of ten cases. Thyroid. 2006 Jan; 16(1):89-93. PMID:16487020. DOI:10.1089/thy.2006.16.89.
  22. Fatourechi V . Hashimoto's encephalopathy: myth or reality? An endocrinologist's perspective. Best Pract Res Clin Endocrinol Metab. 2005 Mar; 19(1):53-66.
  23. Fatourechi V . Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol. 2005; 6(5):295-309. PMID:16252929.
  24. *Basu A, Abu-Lebdeh HS, Erickson D, Bahn RS, Hay ID, Fatourechi V . Recombinant human TSH (rhTSH) for management of metastatic differentiated thyroid carcinoma in patients with deficient endogenous TSH reserve. Int J Endocrinol Metab. 2005; 1:130-35.
  25. Fatourechi V . Subclinical hypothyroidism: when to treat, when to watch? Consultant. 2004 Apr 1; 44(4):533-9.
  26. Fatourechi V , Klee GG, Grebe SK, Bahn RS, Brennan MD, Hay ID, McIver B, Morris JC. Effects of reducing the upper limit of normal TSH values. JAMA: Journal of the American Medical Association. 2003 Dec 24; 290(24):3195-6. PMID:14693871.
  27. Fatourechi V , Bartley GB, Eghbali-Fatourechi GZ, Powell CC, Ahmed DDF, Garrity JA. Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy. Thyroid. 2003 Dec; 13(12):1141-4. PMID:14751035.
  28. Soares-Welch CV, Fatourechi V , Bartley GB, Beatty CW, Gorman CA, Bahn RS, Bergstralh EJ, Schleck CD, Garrity JA. Optic neuropathy of Graves disease: Results of transantral orbital decompression and long-term follow-up in 215 patients. Am J Ophthalmol. 2003 Sep; 136(3):433-41. PMID:12967795.
  29. Robertson DM, Buettner H, Gorman CA, Garrity JA, Fatourechi V , Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh E, Offord KP, Rademacher DM, Stanley NM, Bartley GB. Retinal microvascular abnormalities in patients treated with external radiation for Graves ophthalmopathy. Arch Ophthalmol. 2003 May; 121(5):652-7. PMID:12742842.
  30. Fatourechi V , Aniszewski JP, Fatourechi GZ, Atkinson EJ, Jacobsen SJ. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab. 2003 May; 88(5):2100-5. PMID:12727961. DOI:10.1210/jc.2002-021799.
  31. Fatourechi V , Lankarani M, Schryver PG, Vanness DJ, Long KH, Klee GG. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L). Mayo Clin Proc. 2003 May; 78(5):554-60. PMID:12744541. DOI:10.4065/78.5.554.
  32. Fatourechi V , Ahmed DDF, Schwartz KM. Thyroid acropachy: Report of 40 patients treated at a single institution in a 26-year period. J Clin Endocrinol Metab. 2002 Dec; 87(12):5435-41. PMID:12466333.
  33. Gorman CA, Garrity JA, Fatourechi V , Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Buettner H, Robertson DM, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB. The aftermath of orbital radiotherapy for graves' ophthalmopathy. Ophthalmology. 2002 Nov; 109(11):2100-7. PMID:12414422.
  34. Duininck TM, van Heerden JA, Fatourechi V , Curlee KJ, Farley DR, Thompson GB, Grant CS, Lloyd RV. de Quervain's thyroiditis: surgical experience. Endocr Pract. 2002 Jul-Aug; 8(4):255-8. PMID:12173910.
  35. Schwartz KM, Ahmed DDF, Ahmed I, Fatourechi V . Development of localized myxedema in a skin graft. Int J Dermatol. 2002 Jul; 41(7):401-3. PMID:12121553.
  36. Fatourechi V . Mild thyroid failure [subclinical hypothyroidism]: to treat or not to treat? Compr Ther. 2002 Summer; 28(2):134-9. PMID:12085461.
  37. *Sawka AM, Fatourechi V , Boeve BF, Mokri B. Rarity of encephalopathy associated with autoimmune thyroiditis: a case series from Mayo Clinic from 1950 to 1996. Thyroid. 2002 May; 12(5):393-8. PMID:12097200. DOI:10.1089/105072502760043477.
  38. Fatourechi V , Hay ID, Javedan H, Wiseman GA, Mullan BP, Gorman CA. Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer. J Clin Endocrinol Metab. 2002 Apr; 87(4):1521-6. PMID:11932275. DOI:10.1210/jcem.87.4.8373.
  39. Schwartz KM, Fatourechi V , Ahmed DD, Pond GR. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab. 2002 Feb; 87(2):438-46. PMID:11836263. DOI:10.1210/jcem.87.2.8220.
  40. Fatourechi V . Subclinical hypothyroidism: how should it be managed? Treat Endocrinol. 2002; 1(4):211-6. PMID:15799214.
  41. Gorman CA, Garrity JA, Fatourechi V , Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology. 2001 Sep; 108(9):1523-34. PMID:11535445.
  42. *Heshmati HM, Fatourechi V , Dagam SA, Piepgras DG. Hypopituitarism caused by intrasellar aneurysms. Mayo Clin Proc. 2001 Aug; 76(8):789-93. PMID:11499817. DOI:10.1016/S0025-6196(11)63222-9.
  43. Fatourechi V . Subclinical thyroid disease. Mayo Clin Proc. 2001 Apr; 76(4):413-6; quiz 416-7.  PMID:11322357. DOI:10.4065/76.4.413.
  44. Fatourechi V . Medical treatment of Graves' ophthalmopathy. Ophthalmol Clin North Am. 2000 Dec; 13(4):683-91.
  45. Fatourechi V . How to use the new sensitive thyrotropin assays. Postgrad Med. 2000 Dec; 108(7):25-6. PMID:11126140.
  46. Fatourechi V , Hay ID, Mullan BP, Wiseman GA, Eghbali-Fatourechi GZ, Thorson LM, Gorman CA. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer? Thyroid. 2000 Jul; 10(7):573-7. PMID:10958309.
  47. Fatourechi V , Edwards WD. Graves' disease and low-output cardiac dysfunction: implications for autoimmune disease in endomyocardial biopsy tissue from eleven patients. Thyroid. 2000 Jul; 10(7):601-5. PMID:10958313.
  48. Fatourechi V , Hay ID. Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of serum thyroglobulin monitoring in tumor surveillance. Semin Nucl Med. 2000 Apr; 30(2):107-14.PMID:10787191.
  49. Fatourechi V . Demystifying autoimmune thyroid disease. Which disorders require treatment? Postgrad Med. 2000 Jan; 107(1):127-34. PMID:10649670.
  50. Fatourechi V , Hay I, Mullan B, Wiseman G, Eghbali-Fatourechi G, Thorson L, Gorman C. Post-therapy scans in patients with differentiated thyroid cancer; how often do they influence subsequent management? Annual Meeting of the American Thyroid Association Palm Beach, Florida, 1999.
  51. *Heshmati HM, Fatourechi V , van Heerden JA, Hay ID, Goellner JR. Thyroglossal duct carcinoma: report of 12 cases. Mayo Clin Proc. 1997 Apr; 72(4):315-9. PMID:9121176. DOI:10.1016/S0025-6196(11)63329-6.
  52. Fatourechi V . Hypertension in diabetes: setting and achieving blood pressure goals. Consultant. 1997; 37(6):1624-1630.
  53. *Wermers RA, Fatourechi V , Kvols LK. Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors. Mayo Clin Proc. 1996 Nov; 71(11):1030-8. PMID:8917287. DOI:10.1016/S0025-6196(11)63274-6.
  54. *Ohno K, Yamamoto M, Engel AG, Harper CM, Roberts LR, Tan GH, Fatourechi V . MELAS-and Kearns-Sayre-type co-mutation with myopathy and autoimmune polyendocrinopathy. Ann Neurol. 1996 Sept; 40(3):480.
  55. Fatourechi V , Wermers RA. Glucagon-producing tumors and glucagonoma syndrome. Endocrinologist. 1996 Jul; 6(4):285-93.
  56. Ohno K, Yamamoto M, Engel AG, Harper CM, Roberts LR, Tan GH, Fatourechi V . MELAS- and Kearns-Sayre-type co-mutation [corrected] with myopathy and autoimmune polyendocrinopathy. Ann Neurol. 1996 Jun; 39(6):761-6. PMID:8651648. DOI:10.1002/ana.410390612
  57. Bartley GB, Fatourechi V , Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA. Long-term follow-up of Graves ophthalmopathy in an incidence cohort. Ophthalmology. 1996 Jun; 103(6):958-62. PMID:8643255.
  58. Bartley GB, Fatourechi V , Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA. The chronology of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996 Apr; 121(4):426-34. PMID:8604736.
  59. Bartley GB, Fatourechi V , Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996 Mar; 121(3):284-90. PMID:8597271.
  60. Wermers RA, Fatourechi V , Wynne AG, Kvols LK, Lloyd RV. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine (Baltimore) 1996 Mar; 75(2):53-63. PMID:8606627.
  61. Bartley GB, Fatourechi V , Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA. The treatment of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996 Feb; 121(2):200-6. PMID:8623890.
  62. Fatourechi V , Kennedy FP, Rizza RA, Hogan MJ. A practical guideline for management of hypertension in patients with diabetes. Mayo Clin Proc. 1996 Jan; 71(1):53-8. PMID:8538234. DOI:10.1016/S0025-6196(11)64922-7.
  63. Bartley GB, Fatourechi V , Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA. The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol. 1995 Oct; 120(4):511-7. PMID:7573310.
  64. *Bastanhagh MH, Fatourechi V , Rajabian R. Hydatid cyst presenting as a thyroid nodule. Acta Medica Iranica. 1995; 33:31-4.
  65. Fatourechi V , Bergstralh EJ, Garrity JA, Bartley GB, Beatty CW, Offord KP, Gorman CA. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy. Mayo Clin Proc. 1994 Sep; 69(9):841-8. PMID:8065185.
  66. Fatourechi V , Garrity JA, Bartley GB, Bergstralh EJ, DeSanto LW, Gorman CA. Graves ophthalmopathy. Results of transantral orbital decompression performed primarily for cosmetic indications. Ophthalmology. 1994 May; 101(5):938-42. PMID:8190484.
  67. Fatourechi V , Pajouhi M, Fransway AF. Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases. Medicine (Baltimore) 1994 Jan; 73(1):1-7. PMID:8309359.
  68. Garrity JA, Fatourechi V , Bergstralh EJ, Bartley GB, Beatty CW, DeSanto LW, Gorman CA. Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy. Am J Ophthalmol. 1993 Nov 15; 116(5):533-47. PMID:8238212.
  69. Fatourechi V , Garrity JA, Bartley GB, Bergstralh EJ, Gorman CA. Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema. J Endocrinol Invest. 1993 Jun; 16(6):433-7. PMID:8370919.
  70. Fatourechi V , Bartley GB, Garrity JA, Bergstralh EJ, Ebersold MJ, Gorman CA. Transfrontal orbital decompression after failure of transantral decompression in optic neuropathy of Graves' disease. Mayo Clin Proc. 1993 Jun; 68(6):552-5. PMID:8497132.
  71. Garrity JA, Saggau DD, Gorman CA, Bartley GB, Fatourechi V , Hardwig PW, Dyer JA. Torsional diplopia after transantral orbital decompression and extraocular muscle surgery associated with Graves' orbitopathy. Am J Ophthalmol. 1992 Apr 15; 113(4):363-73. PMID:1558109.
  72. Garrity JA, Saggau DD, Gorman CA, Bartley GB, Fatourechi V , Hardwig PW, Dyer JA. Torsional diplopia after transantral orbital decompression and extraocular muscle surgery associated with Graves' orbitopathy. Am J Ophthalmol. 1992; 114:239-40. PMID:1642313.
  73. Fatourechi V , Bartley GB, DeSanto LW, Harner SG, Bergstralh E, Garrity JA. Efficacy of transantral orbital decompression for the treatment of Graves' optic neuropathy. Thyroid. 1991; 1(Suppl 1):8-12.
  74. Fatourechi V , Gharib H. Hyperthyroidism following hypothyroidism. Data on six cases. Arch Intern Med. 1988 Apr; 148(4):976-8. PMID:3281622.
  75. Fatourechi V , Khatami M. Recurrent nerve paralysis in a patient with tuberculosis of the thyroid. Medical Journal of Beheshti University (Persian Language) 1988; 12:126-30.
  76. Fatourechi V , Heath H 3rd. Salmon calcitonin in the treatment of postmenopausal osteoporosis. Ann Intern Med. 1987 Dec; 107(6):923-5. PMID:3318613.
  77. *Meybodi HA, Fatourechi V . Osteomalacia induced by antiepileptic therapy in Iran. Iranian Medical Council Journal. 1987 (Persian language).
  78. Abbassiuon K, Fatourechi V , Amirjamshidi A, Meibodi NA. Familial acromegaly with pituitary adenoma: report of three affected sibling J Neurosurgery. 1986; 64:510-2.
  79. Fatourechi V , Heybodi A, Ghavamzadeh A. Hyperthyroidism associated with trophoblastic disease. Iranian Medical Council Journal (Persian Language) 1985; 9:325-30.
  80. Fatourechi V , Gharib H, Scheithauer BW, Meybody NA, Gharib M. Pituitary thyrotropic adenoma associated with congenital hypothyroidism. Report of two cases. Am J Med. 1984 Apr; 76(4):725-8. PMID:6711578.
  81. *Meybodi HA, Fatourechi V , Bastanhagh MH. Tumor-induced hypoglycemia: Report of a case. Medical Journal of the National University of Tehran (Persian language) 1984; 8:133-9.
  82. Fatourechi V . The relationship of serum uric acid to serum lipids: A study of young subjects in Iran. Acta Medica Iranica 1983; 25:l-15.
  83. Sheikhzadeh AH, Fatourechi V , Payedar D, Nazarinn I. Unusual Cardiovascular manifestations in a case of pheochromocytoma. Clin Cardiol. 1983; 6:156-42. PMID:6839569.
  84. *Meybodi HA, Fatourechi V , Saleh M. A report of autonomic dysreflexia in cord injuries. Iranian Medical Council Journal (Persian Language) 1983; 9:1-6.
  85. Fatourechi V , Botorabi Z, Jahangiri N. A Report of 2150 Thyroid Scans. The Iranian Medical Council Journal (Persian language) 1983; 9:109-13.
  86. Fatourechi V , Scheikzadeh AH, Ghavam H. Obstructive Cardiomyopathy in a Male Dwarf with Cryptochidism. Clin Cardiol. 1982; 5:301-3. PMID:6123397.
  87. Fatourechi V , Hatami M, Shariatmadari T. A report of 12 cases of isolated tuberculosis of thyroid. The Iranian Medical Council Journal (Persian language) 1982; 8:395-9.
  88. *Ghasemabadi AN, Fatourechi V . An update of insulin therapy. Medical Journal of National University of Iran (Persian Language) 1981; 7:35-9.
  89. Fatourechi V , Moezi B, Ghazvinian R, Eghbali G. Plasma Digoxin and Magnesium Concentrations in Open Heart Surgery. J Cardiovasc Surg. 1979; 20:151-8.
  90. Fatourechi V , Roustaian K. Thyroid Storm in Hyperthyroidism Treated With Propranolol. Iranian Medical Council Journal. 1978; 6:500-4.
  91. *Moezzi B, Fatourechi V , Kozain R, Eslami B. The effect of penicillamine on serum digoxin levels. Jpn Heart J. 1978 May; 19(3):366-75. PMID:691271.
  92. Fatourechi V . Endocrinology of Calcium Absorption. Medical Journal of National University of Iran (Persian Language) 1978; 5:221-4.
  93. Vakili C, Azizi M, Fatourechi V . Distribution of nodules in thyroid lobes. Pahlavi Medical Journal. 1978; 9:289-95. PMID:714493.
  94. *Haghighat H, Fatourechi V . Endocrine studies in myotonic dystrophy. Medical Journal of the National University of Iran. 1977; 7:35-9.
  95. Hadidi A, Fatourechi V , Hedayat A. A clinical trial of thyroid ultrasonography and its value. The Iranian Medical Council Journal (Persian language) 1977; 5:398-404.
  96. Vakili C, Fatourechi V . Age Distribution of Patients with Carcinoma of the Colon in a General Hospital in Iran. Surgery. 1976; 79:118-9. PMID:1246686.
  97. *Alavi F, Moezi B, Fatourechi V . Renin-angiotensin-aldosterone system: A review. Cardiovascular Journal of the Heart Center. Page 16, 1975.
  98. Fatourechi V , Moezzi B, et al. Value of digoxin radioimmunoassay: A clinical trial. The Iranian Heart Journal (Persian language). 1:66-72, 1975.
  99. Aram H, Fatourechi V . Werner's Syndrome: First reported cases in Iran. Curtis. 14:215-8, 1974.
  100. Fatourechi V , Marvasti MA. Review of Unusual Causes of Hyperthyroidism. Journal of Medical Council of Iran (Persian Language) 4:218-21, 1973.
  101. Molnar GD, Taylor WF, Langworthy A, Fatourechi V . Diurnal growth hormone and glucose abnormalities in unstable diabetics: studies of ambulatory-fed subjects during continuous blood glucose analysis. J Clin Endocrinol Metab. 1972 May; 34:837-846. PMID:5012495.
  102. Fatourechi V , Marvasti MA. Unusual Manifestations of Hyperthyroidism. Journal of Medical Council of Iran (Persian Language) 2:504-9, 1972.
  103. Fatourechi V , McConahey WM, Woolner LB. Hyperthyroidism associated with histologic Hashimoto's thyroiditis. Mayo Clin Proc. 1971 Oct; 46:682-689. PMID:5171000.
  104. Molnar GD, Fatourechi V , Ackerman E, Taylor WF, Rosevear JW, Gatewood LC, Service FJ, Moxness KE. Growth hormone and glucose interrelationships in diabetes: studies of inadvertent hypoglycemic episodes during continuous blood glucose analysis. J Clin Endocrinol Metab. 1971 Mar; 32(3):426-37. PMID:5100000.
  105. Fatourechi V , Molnar GD, Service FJ, Ackerman E, Rosevear JW, Moxness KE, Taylor WF. Growth hormone and glucose interrelationships in diabetes: studies with insulin infusion during continuous blood glucose analysis. J Clin Endocrinol Metab. 1969 Mar; 29(3):319-27. PMID:5773066.
  106. Molnar GD, Fatourechi V , Service FJ. Diabetes mellitus. Outline of methods for early diagnosis. Minn Med. 1967 Mar; 50(3):309-13. PMID:6039850.

Books

  1. Hemmati H, Nedjat M, Nassiri P, Fatourechi V . Pathophysiology of Endocrine Disorders (Translation from English to Persian). Teheran, Iran, 1984. (Book)
  2. Gharib H, Fatourechi V , Moezi B. Principles of Endocrinology. (Persian language). Tehran, Iran, 1976. (Book)

Book Chapters

  1. Fatourechi V . Hyperthyroidism and thryrotoxicosis. In: Bandeira F; et al, editor. Endocrinology and diabetes: a problem-oriented approach. New York: Springer; 2014. p. 9-21. (Book chapter)
  2. Fatourechi V . Thyroid Demopathy and Acropachy. In: Best Practice and Research Clinical Endocrinology and Metabolism 26. Elsevier; 2012. p. 553-565. (Book chapter)
  3. Fatourechi V . A 26-year-old woman with goiter and neck discomfort. In: Diagnostic Dilemmas: Images in Endocrinology. Maryland: The Endocrine Society; 2011. (Book chapter)
  4. Fatourechi V . Pretibial myxedema (thyroid dermopathy). In: Heymann WR, editor. Thyroid disorders with cutaneous manifestations. Marlton: Springer; 2008. p. 103-19. (Book chapter)
  5. Schiefer R, Fatourechi V . Laboratory diagnosis of thyroid disease. In: Heymann WR, editor. Thyroid disorders with cutaneous manifestations. Marlton: Springer; 2008. p. 23-36. (Book chapter)
  6. Fatourechi V . Thyroid Dermopahy In: Cutaneous Manifestations of Thyroid Diseases 2007. (Book chapter)
  7. Fatourechi V . Thyroid Function Tests In: Cutaneous Manifestations of Thyroid Disease 2007. (Book chapter)
  8. Fatourechi V . Thyroiditis In: Conn's Current Therapy Elsvier-Saunders; 2006. (Book chapter)
  9. Fatourechi V . Hyperthyroidism In: Conn's Current Therapy Elsvier-Saunders; 2005. (Book chapter)
  10. Rosenberg AM, Fatourechi V . Thyroid disease. In: Lang RS, Hensrud DD. Clinical preventive medicine. 2nd ed. Chicago: American Medical Association; 2004. p. 735-42. (Book chapter)
  11. Fatourechi V . Thyroid dermopathy and acropachy. Thyroid Text book. Editors: L. Braverman and R. Utiger, Jan, 2000. (Book chapter)
  12. Fatourechi V . Graves' disease: localized myxedema and thyroid acropachy. In: Braverman LE, Utiger RD, editors. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text. Eighth Edition. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 548-55. (Book chapter)
  13. Fatourechi V . Localized Myxedema and Thyroid Acropachy. Thyroid 1996, Werner J. (Book chapter)
  14. Fatourechi V . Graves' disease: localized myxedema and thyroid acropachy. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's The Thyroid. Philadelphia: Lippincott-Raven Publisher; 1996. p. 553-8. (Book chapter)

Editorials

  1. Fatourechi V . Graves Ophthalmopathy: Continuing Quest in Search of Initiating Factors and New Therapies. Endocrine Practice (4)/June 412-4 2008 May/June; Vol 14.
  2. * Fatourechi V . Upper limit of normal serum thyroid-stimulating hormone: a moving and now an aging target? J Clin Endocrinol Metab. 2007 Dec; 92(12):4560-2. PMID:18056780. DOI:10.1210/jc.2007-2285.
  3. Fatourechi V . Subclinical hypothyroidism International Journal of Endocrinology. 2006.
  4. Fatourechi V . Salmon calcitonine in Therapy of Osteoporosis Annals of Internal Medicne. 1988.

Commentaries

  1. Fatourechi V . Adverse effects of subclinical hyperthyroidism. Lancet. 2001 Sep 15; 358(9285):856-7. PMID:11567696. DOI:10.1016/S0140-6736(01)06036-6.

Audio/Video/CD-ROM/etc.

  1. Fatourechi V , Kennedy FP, Rizza RA, Hogan MJ. Treating hypertension in patients with diabetes. PrimePractice (2(4) 1996; 2(2).

Letters

  1. Fatourechi V . Subclinical hypothyroidism: Why wait to treat? Consultant. 2004; 44(7):904.
  2. Sawka AM, Fatourechi V . Subclinical thyroid dysfunction and the heart. Ann Intern Med. 2003 Nov 18; 139(10):866. PMID:14623630.
  3. Bartley GB, Fatourechi V , Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA. Author Reply. Am J Ophthalmol. 1996; 122:600.

Abstracts

  1. Haase AQ, Rajkumar SV, Fatourechi V . Effect of therapy with thalidomide derivatives on thyroid function in multiple myeloma. Endocr Rev. 2010 Jun; 31(Suppl 1).
  2. Fatourechi V . Multiple poster session presentations in national meetings of Endocrine Society, American Association of Clinical Endocrinologists, and American Thyroid Association 2004-2008. Endocrine Society. 2008.
  3. Bryan RE, Jenkins GD, Fatourechi V . Graves ophthalmopathy before and after radioactive iodine therapy of Graves' disease in a community cohort. Thyroid. 2004 Sep; 14(9):716.
  4. Booya F, Sebo TJ, Fatourechi V . Primary squamous cell carcinoma of the thyroid: report of 10 cases. Thyroid. 2004 Sep; 14(9):725.
  5. Fatourechi V , Smith J, Schryver P, Klee G. Atrial fibrillation is associated with higher frequency of mild thyroid failure (serum TSH 5.1-10 mIU/L) (Abstract 162). Thyroid. 2003 Jul; 13(7):162.
  6. Tebben P, Fatourechi V . Development of Graves' disease under adequate immunosuppression in a cardiac transplant patient (Abstract 26). Thyroid. 2003 Jul; 13(7):678.
  7. Moayedoddin B, Fatourechi V . Liver enzyme abnormalities and anemia in subacute granulomatous thyroiditis (Abstract 65). Thyroid. 2003 Jul; 13(7):690.
  8. Powell J, Hay I, Morgan M, Mullan B, Wiseman G, Smallridge R, Fatourechi V . A serum thyroglobulin (Tg) level
  9. Fatourechi V , Klee GG. Subclinical hypothyroidism: Lessons from regional and referral practice. 45es Journees Internationales D'Endocrinologie Clinique. 2002 May 23-24.
  10. Castillo PR, Boeve BF, Caselli RJ, Vernino SA, Lucchinetti C, Swanson JW, Noseworthy JH, Askamit AJ, Flemming KD, Hunder GG, Fatourechi V , Mokri B, Lennon VA. Steroid responsive encephalopathy associated with thyroid autoimmunity: clinical and laboratory findings. Neurology. 2002; 58(Suppl):A248.
  11. Fatourechi V , Hay I, Javedan H, Wiseman G, Mullan B, Gorman C. Lack of Impact of Radioiodine Therapy in Thyroglobulin-Positive Diagnostic Scan-Negative Patients With Follicular Cell-Derived Thyroid Cancer(abstract). 73rd Annual Meeting of the American Thyroid Association, Washington DC. 2001 Sept 13-16.
  12. Castillo P, Boeve B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Flemming K, Hunder G, Fatourechi V , Mokri B, Lennon VA. Steroid-responsive encephalopathy associated with thyroid autoimmunity: clinical and laboratory findings. 17th World Congress of Neurology, London. 2001 Jun 17 -22.
  13. Powell JG, Hay ID, Wiseman GA, Mullan BP, Fatourechi V . Role of recombinant human TSH Stimulation in altering management of patients with follicular cell-derived thyroid carcinoma and undetectable serum thyroglobulin levels on thyroxine suppressive therapy. Endocrine Society. Annual Meeting, Program and Abstracts. 2001:410. Abstract no. P2-541.
  14. Fatourechi V , Boeve BF, Mokri B. Encephalopathy associated with autoimmune thyroiditis. Endocrine Society. Annual Meeting, Program and Abstracts. 2001:484. Abstract no. P3-163.
  15. Castillo P, Boeve B, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Fleming K, Hunder G, Fatourechi V , Mokri B, Lennon V. Steroid-responsive encephalopathy associated with thyroid autoimmunity: clinical and laboratory findings. J Neurol Sci. 2001; 187(suppl 1):S492.
  16. Boeve B, Castillo P, Caselli R, Vernino S, Lucchinetti C, Swanson J, Noseworthy J, Aksamit A, Flemming K, Hunder G, Fatourechi V , Mokri B, Lennon V. Steroid-responsive encephalopathy associated with thyroid autoimmunity: outcome with immunomodulatory therapy. J Neurol Sci. 2001; 70(6):S441.
  17. Fatourechi V , Schryver PG, Lankarani M, Vanness DJ, Long KH, Klee GG. Increased prevalence of mildly elevated serum TSH levels in patients with coronary heart disease compared to controls. Endocr J. 2000 Aug; 47(Suppl):193.
  18. Lankarani M, Klee GG, Schryver PG, Vanness DJ, Long KH, Fatourechi V . Progression of hypothyroidism in patients with mildly elevated TSH (5-10mIU/L). Endocr J. 2000 Aug; 47(Suppl):193.
  19. Fatourechi V , Lankarani M, Schryver PG, Vanness DJ, Long KH, Klee GG. Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly elevated serum TSH (5-10 mIU/L) (Abstract #2458). Endocrine Society 82nd Annual Meeting. 2000.
  20. Basu A, Erickson D, Bahn R, Fatourechi V . Use of recombinant human TSH (rhTSH) prior to radioiodine therapy in a case of hypopituitarism due to metastatic follicular thyroid cancer. Endocrine Society Toronto, Ontario, Canada. 2000 Jun 21-24.
  21. Fatourechi V , Hay I, Mullan B, Wiseman G, Thorson L, Gorman C. How often do post-therapy scans in thyroglobulin-positive, diagnostic scan-negative patients with differentiated thyroid cancer show meaningful uptake in areas of known metastases? 72nd Annual Meeting of the American Thyroid Association Palm Beach, FL. 1999.
  22. Fatourechi V . For Graves' ophthalmopathy. Annual Meeting of the American Thyroid Association Palm Beach, FL. 1999.
  23. Aniszewski J, Abu-Lebdeh H, Klimiuk P, Fatourechi V . Myasthenia Gravis Associated With Graves' Ophthalmopathy and Euthyroid Graves' Disease. Annual Meeting of the American Thyroid Association, Palm Beach, Fl. 1999.
  24. Aniszewski JP, Klimiuk P, Fatourechi V . Long-Term Follow-up of Subacute Thyroiditis in an Incidence Cohort American Association of Clinical Endocrinologists. Eighth Annual Meeting & Clinical Congress, San Diego, CA. 1999.
  25. Aniszewski JP, Fatourechi V , Atkinson EJ, Jacobsen SJ, O'Fallon MW. The Incidence of Subacute Thyroiditis in Olmsted County Minnesota. The Endocrine Society's 81st Annual Meeting , San Diego, CA. 1999.
  26. Fatourechi V , Edwards WD. Is Graves' Disease Associated With Autoimmune Cardiomyopathy? 71st Annual Meeting of the American Thyroid Association, Portland, Oregon. 1998.
  27. Heshmati HM, Fatourechi V . Hypopituitarism Caused by Intrasellar Aneurysm: Report of 7 Cases. Endocrine Society. 1996.
  28. Bartley G, Fatourechi V , Kadrmas E, Jacobsen S, Ilstrup D, Garrity J, Gorman C. The treatment and long-term follow-up of Graves' ophthalmopathy in an incidence cohort. 26th Annual Scientific Symposium of the American Society of Ophthalmic Plastic and Reconstructive Surgery, Atlanta, GA. 1995 Oct.
  29. Bartley GB, Fatourechi V , Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA. Graves' ophthalmopathy in an incidence cohort. (Abstract no. 362) p. 80. Thyroid. 1995 Sep; 5(Suppl 1):S-182.
  30. Yamamoto M, Ohno K, Engel AG, Roberts LR, Tan GH, Fatourechi V . Large-scale deletion and an A3243G mutation of mitochondrial DNA (mtDNA) in the same patient. (Abstract no. 973s). Neurology. 1995 Apr; 45(Suppl):A434-435.
  31. Fatourechi V . Clinical spectrum of hyperglucagonemia. AACE Chicago. 1995.
  32. Wermers RA, Fatourechi V , et al. Glucagonoma Syndrome Tumors. Endocrine Society. 1995.
  33. Heshmati HM, Fatourechi V , Van Heerden JA, Hay ID, Goellner JR. Thyroglossal duct cyst carcinoma: a survey of 12 cases. (Abstract no. P2-685). Program Abstr Endocr Soc Annu Meet. 1995; 462.
  34. Wermers RA, Kvols L, Fatourechi V . The spectrum of hyperglucagonemia in islet cell tumors. (Abstract P3-261). Program Abstr Endocr Soc Annu Meet. 1995; 534.
  35. Roberts LR, Tan GH, Ohno K, Yamamoto H, Engel AG, Fatourechi V . Autoimmune polyglandular syndrome (APS) type II and Kearns-Sayre syndrome. (Abstract no. P3-315). Program Abstr Endocr Soc Annu Meet. 1995; 547.
  36. Bartley G, Fatourechi V , Kadrmas E, Jacobsen S, Ilstrup D, Garrity J, Gorman C. The incidence of Graves' ophthalmopathy. Annual Meeting of the American Society of Ophthalmic Plastic and Reconstructive Surgery, San Francisco, California. 1994 Oct.
  37. Cheng SS, Cuddihy RM, Fatourechi V , Carpenter PC, Carpenter HA, Sterioff S, Munn SR. Recurrence of diabetes mellitus with triple-drug immunosuppression following combined kidney-pancreas transplantation. 4th International Congress on Pancreas and Islet Transplantation, Program and Abstracts, 1993 1993; P14.
  38. Cheng S, Cuddihy RM, Fatourechi V , Carpenter PC, Carpenter HA, Sterioff S, Munn Sr. Recurrence of diabetes mellitus with triple-drug immunosuppression following combined kidney-pancreas transplantation. ICPIT '93 University Hospital, Groningen, The Netherlands. 1993.
  39. Fatourechi V , Garrity J, Bartley G, Bergstralh E, Gorman C. Predictors of operative results in Graves' ophthalmopathy. 66th Meeting American Thyroid Association Inc, Rochester, MN. 1992 Sept.
  40. Garrity J, Fatourechi V , Bergstralh E, Bartley G, Gorman C. Results of transantral orbital decompression (TAD) in 428 patients with severe Graves' ophthalmopathy. 66th Meeting American Thyroid Association Inc, Rochester, Minnesota, 1992 Sep.
  41. * Pajouhi M, Fatourechi V . Temporal relationship between onset of thyroid dermopathy (pretibial myxedema) and diagnosis of hyperthyroidism. Ninth International Congress of Endocrinology Nice, France, 1992.
  42. Gorman CA, Fatourechi V , Garrity J, Bergstralh E, Bartley G. Predictors of proptosis recession from transantral orbital decompression (TAD) for Graves' ophthalmopathy (GO). 65th Meeting American Thyroid Association, Boston, MA. 1991 Sept.
  43. Garrity J, Saggau D, Gorman CA, Fatourechi V , Bartley G, Dyer J. Torsional diplopia following transantral orbital decompression for Graves' orbitopathy. An analysis of 26 cases International Symposium on Graves' Ophthalmopathy Amsterdam, The Netherlands. 1991.
  44. Fatourechi V , Hatami M. Isolated tuberculosis of the thyroid: A report of 12 cases. American Thyroid Association Inc, 58th Annual Meeting. 1982 Sept 22-25.
  45. Fatourechi V , Moezi B, Khozein R, Eslami B. The effect of penicillamine on serum digoxin level. Annual Meeting Southern Society for Clinical Investigation, San Francisco, California. Jan 27-28, 1978.
  46. Fatourechi V , Moezi B, Khozein R. Value of serum digoxin measurement in digitalis toxicity. The Eighth Pahlavi Medical Congress. 1977 May 3-5.
  47. Fatourechi V . Diagnostic Approach to Diabetes Mellitus. 26th International Iranian Medical Congress Ramsar September 1-15, 1977.
  48. Molnar GD, Fatourechi V , Service FJ, Ackerman E, Rosevear JE, Taylor WF. Stress and growth hormone release during continuously monitored hypoglycemia. Int Congr Ser. 1971; 236:50-51.
  49. Molnar GD, Fatourechi V , Service FJ, Ackerman E, Rosevear JW, Taylor WF. Growth hormone (GH) release in diabetics during insulin reactions (IR) and comparable insulin infusion tests (iit). Clin Res. 1970 Oct; 18:625.
  50. Molnar GD, Fatourechi V , Ackerman E, Rosevear JW, Service FJ, Taylor WF, Moxness KE. Growth hormone and blood glucose interrelationships during continuously monitored hypoglycemia. Int Congr Ser. 1970; 209:61-62.
  51. Molnar GD, Fatourechi V , Rosevear JW, Service FJ, Moxness KE, Ackerman E, Taylor WF. Plasma growth hormone (GH) levels during hypoglycemic episodes (he) and insulin infusion tests (iit). Diabetes. 1969; 18(Suppl 1): 366.
  52. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Cremer GM, Fatourechi V , Moxness KE. Biochemical and hormonal profile of diabetic instability. Diabetes. 1968; 17(Suppl 1):342.
  53. Fatourechi V , Moxness KE, Molnar GD, Ackerman E, Rosevear JW, Service FJ. Diurnal plasma levels of growth hormone and diabetic instability. Diabetes. 1967 Jul; 16:504.
  54. Service FJ, Rosevear JW, Molnar GD, Ackerman E, Pfaff KJ, Fatourechi V . Continuous blood glucose recording in the study of diabetic instability. Diabetes. 1967 Jul; 16:535.

Forthcoming

  1. Fatourechi V . 2008 Update on subclinical hypothyroidism. Mayo Proceedings submitted. 2008.
  2. Fatourechi V . Long term outcome of therapy of Graves' hyperthyroidism: Mayo Experience 2007.

    3. *Indicates that the primary author was a mentee of this author

 

Vahab Fatourechi

Professor of Medicine



  • DEPARTMENTEndocrinology, Diabetes, Metabolism and Nutrition
    Minnesota
  • COUNTRYUSA